Latest Interviews

What is the Future of Hollywood?

Ben Horowitz, Marc Andreessen, Blake Snyde

Amidst the 2023 Hollywood strikes triggered by streaming economics, industry leaders analyzed how artificial intelligence and blockchain will disrupt traditional production models by automating generic content while preserving value for unique human creativity. The discussion projects a bifurcated future where low-cost AI-generated media saturates the market alongside premium, human-made art, alongside potential societal risks of emotional manipulation and cultural homogenization. Ultimately, experts anticipate that these technologies will democratize filmmaking through laptop-based production, empower independent creators via smart contracts, and potentially extend the cultural impact of deceased artists through synthetic licensing.

E147: TED goes woke, Canada's Nazi blunder, AI adds vision, plus: who owns OpenAI?

Coleman Hughes, Sam Altman, David Sacks, Friedberg

Coleman Hughes describes a conflict with TED following his talk on colorblindness, alleging that staff censorship suppressed the video's visibility to appease ideological objections and prevent the release of a debate. He argues this incident illustrates how institutional capture occurs when employee values override leadership intent, leading to the marginalization of viewpoints like those regarding racial identity and policy. Additionally, the discussion expands to critique perceived incompetence in Western political leadership regarding historical contexts in Ukraine and analyzes emerging trends in AI, including OpenAI's valuation strategies and the potential for language models to replace traditional operating systems.

How Surbhi Sarna Built A $275M Biotech Company From Nothing

Surbhi Sarna, Ryan Briggs

Serby Serna founded Envision Medical to develop the first FDA-cleared device for early ovarian cancer detection, overcoming significant investor bias by securing seed funding before raising $20 million to advance the technology. The company achieved a $275 million acquisition by Boston Scientific after demonstrating clinical viability, marking a successful exit for Serna who previously faced rejections based on her lack of advanced degrees. Now a Group Partner at Y Combinator, Serna leverages her experience to advocate for biotech founders based on problem-solution fit rather than traditional academic credentials.

Kevin Niparko: Big Mistakes Founders Make When Hiring Product Teams | E1066

Kevin Niparko, Harry Stebbings

This session features insights from product leaders discussing a philosophy that prioritizes observing customer workflows over feature requests to drive major trends. The discussion outlines a framework for scaling product teams by balancing art and science, implementing weekly demos as a forcing function, and allocating resources across three innovation horizons. Additionally, the event provides strategic guidance on hiring generalist leaders, avoiding the build trap, and timing the introduction of secondary products to sustain core growth.

All-In Summit: Jenny Just on Peak6, the female market correction, poker, and risk

Jenny Just, Chamath, Calacanis, Friedberg

Jenny, founder of the multi-billion dollar financial services firm Peak Six, leveraged her company's century-long trading track record to advocate for bridging the gender gap in finance through strategic risk-taking. She launched the "Poker Power" initiative to teach probability and capital allocation to millions of women, aiming to normalize early risk exposure and dismantle the confidence gap that hinders female participation. With Peak Six currently holding record inventory in anticipation of a volatility-driven market correction, the firm combines its "long volatility" investment thesis with a broader mission to reshape the industry's demographic landscape over the next five years.

Mark Zuckerberg: First Interview in the Metaverse | Lex Fridman Podcast #398

Mark Zuckerberg, Lex Fridman

Meta demonstrated photorealistic 3D avatar technology through a remote conversation between Mark Zuckerberg and Lex Friedman, utilizing efficient codec compression to transmit subtle facial imperfections and spatial audio for enhanced emotional presence. This capability is slated for integration into the upcoming $500 Quest 3 headset, which features advanced mixed reality pass-through and latency-free hand tracking to blend digital avatars with physical environments. Looking forward, the roadmap includes reducing avatar scanning time to minutes via smartphones and deploying AI-generated personas to transform remote work, social connection, and creative interactions within a unified digital-physical reality.

Spotify Founder: How A 23 Year Old Introvert Built A $31 Billion Business!

Whitney Wolfe Herd, Daniel Ek

Spotify co-founder Daniel Ek details the high-stakes journey of transforming a bankrupt music industry into a $50 billion entity by leveraging his generalist strengths and relying on a stabilizing partnership with co-founder Martin Lorentzon. Facing near-death financial crises and personal physical tolls during two years of licensing negotiations, Ek navigated competition from tech giants like Apple through strategic focus on cross-platform ubiquity and superior personalization algorithms. The narrative concludes with Ek's evolved leadership philosophy, which prioritizes a culture of calculated risk-taking and self-directed learning over traditional specialist expertise to guide the company's expansion into podcasting and audio content.

Longevity: can ageing be reversed?

Experts project that treatments to reverse biological age could emerge within five decades, driven by breakthroughs such as epigenetic reprogramming and genetic interventions like those modifying the *DAF2* gene. These scientific advances, supported by studies on dietary restriction and the health benefits of centenarians, are attracting significant capital to develop therapies targeting senescent cells and common drugs like Metformin. The resulting economic imperative aims to reduce the burden of age-related disease while transforming the demographic challenge of an aging population into a trillions-of-dollars opportunity.

All-In Summit: AI film and the generative art revolution with Caleb Ward

Caleb Ward, Wes Anderson, Chamath, Calacanis, Friedberg, David Sacks

Caleb Ward, CEO of Curious Refuge, demonstrates how current generative AI tools can independently produce scripts, visuals, and audio for film within hours for under $10, though human curation remains essential for narrative coherence. By transitioning from training VFX studios to a global bootcamp, his organization is enabling diverse creators ranging from Academy Award winners to young students to integrate these hybrid workflows into professional pipelines. Ward predicts a future shift toward personalized "prompt-to-media" content, emphasizing that while technical barriers are lowering, the critical challenge lies in parameterizing human creative decision-making to solve for emotional resonance.

Christian Lanng: "How Being a Founder Almost Killed Me" | E1065

Christian Lanng, Harry Stebbings

Following a severe health crisis and realization of deep burnout after 14 years, TradeShift co-founder Christian resigned from his executive role to prioritize well-being and address a "valuation trap" caused by early high-finance decisions. Transitioning into a new venture called "Beyond Work," he now advocates for AI-first architectures that eliminate traditional software interfaces while arguing that proprietary data and trust are the primary competitive moats for future enterprise solutions. His revised investment philosophy favors second-time founders and a "Beyond Work" vision designed to automate corporate tasks by placing humans at the center of workflows rather than forcing them to adapt to rigid systems.

All-In Summit: In conversation with Vinod Khosla

Vinod Khosla, Chamath, Calacanis, Friedberg

Khosla Ventures founder Vinod Khosla, drawing on a career managing Sun Microsystems and achieving massive returns in networking firms, criticizes conventional venture capital for prioritizing short-term recaps over the brutal honesty required to build foundational innovations. He outlines a strategic shift toward investing in alternative AI methodologies and hard tech like Helion Energy's fusion architecture, arguing that long-term fundamental value persists despite market volatility. Looking twenty-five years ahead, Khosla predicts the obsolescence of traditional work necessitating a societal redefinition of human purpose and potential economic models like Universal Basic Income to manage displacement and reduce income disparity.

All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk

Dr. Nicole Paulk, Chamath, Calacanis, Friedberg

Dr. Nicole Paul's Siren Biotechnology is transitioning from stealth to clinical trials with a universal AAV platform designed to treat cancer by engineering viral logic circuits that reactivate immune surveillance against invisible tumors. Preclinical data demonstrates functional cures in human brain cancer models, positioning the company to launch its first trial in 2025 despite facing significant industry headwinds including manufacturing bottlenecks and restrictive FDA regulations. While the immediate focus remains on oncology, the technology aims to eventually enable human augmentation and longevity applications, contingent upon future regulatory shifts regarding non-disease therapeutic targets.

How to get Washington and Silicon Valley to tame AI | Mustafa Suleyman

Mustafa Suleyman, Michael Bhaskar, Rob

Inflection AI co-founder Mustafa Suleiman outlines a strategy where his company develops safer, larger language models like Pi to outpace bad actors while avoiding the premature pursuit of autonomous self-improvement. He advocates for mandatory government regulations including scale audits and bans on electioneering to manage immediate misuse risks, rejecting the open-sourcing of future frontier models that could destabilize global security. Suleiman argues that rapid technological progress in the US-China "economic war" necessitates a shift from voluntary safety commitments to binding legal frameworks to prevent existential threats from emerging technologies.

Universally Accessible Intelligence with Character.ai's Noam Shazeer

Noam Shazeer, Sarah Wang

Co-founder Noam Shazeer details Character.ai's vertically integrated strategy to accelerate AGI development by prioritizing generalizable dialogue models over domain-specific applications, a choice that has driven over 20 billion messages and sustained two hours of daily engagement per user. The company leverages current scaling laws to rapidly reduce training costs while projecting a model tens of IQ points smarter by year-end alongside multimodal enhancements like voice and long-term memory. Shazeer frames the technology as a pre-AGI breakthrough comparable to the Wright Brothers' first flight, predicting ubiquitous, affordable intelligence within a year as global H100 infrastructure expands, while dismissing immediate existential risks in favor of a four-month pause for safety verification.

Democratizing Design with Figma's Dylan Field

Dylan Field, David George

Figma is redefining the design industry by integrating AI agents like JamBot to transform linear workflows into non-linear exploration, effectively collapsing traditional boundaries between design and development roles. While the company acknowledges that foundational models are trending toward commoditization, it leverages its unique abstract syntax tree to position its platform as a critical bridge from "systems of record" to predictive and actionable interfaces. This strategic pivot aims to accelerate product cycles by lowering the barrier to entry for broader teams while maintaining human judgment as the essential differentiator for final production quality.